Agent auxiliary diffusion device

Abstract

The utility model provides a medicament auxiliary diffusion device, which is arranged in a reaction cavity, and comprises a main body frame, the main body frame comprises a cylinder body with two through ends, one end of the cylinder body faces the bottom of the reaction cavity, the other end of the cylinder body deviates from the bottom of the reaction cavity, and a plurality of holes are formed in the cylinder wall of the cylinder body; the limiting unit is connected with the main body frame, the limiting unit comprises a first limiting assembly and a second limiting assembly, the first limiting assembly is used for limiting the end, deviating from the bottom of the reaction cavity, of the barrel to be not lower than the liquid level, and the second limiting assembly is used for limiting the barrel to be below the medicament adding opening, so that a medicament added by the medicament adding opening falls into the barrel; and the aeration assembly is connected with the main body frame, and the aeration assembly is used for aerating the cylinder. According to the utility model, the diffusion speed of the medicament is higher and more uniform when the medicament is added, so that the medicament is dissolved more quickly and more fully, the dissolving effect is improved, the usage amount of the medicament is reduced, and the water quality index is better improved.

Description

Technical Field

[0001] This utility model relates to the field of water treatment, and in particular to a reagent-assisted diffusion device. Background Technology

[0002] With rapid economic development, pollution caused by production and daily life has become increasingly severe. Water pollution, in particular, has impacted normal life and production in my country. Sewage and wastewater contain large amounts of toxic and harmful impurities, causing serious damage to the surrounding environment. Therefore, reducing water pollution has become a key research task in my country, and effective water treatment and pollution reduction are the main tasks of current environmental protection projects.

[0003] With the development of modern society, the control precision of various production equipment is becoming increasingly higher, especially in water treatment equipment, where the precise control of the dosing of various chemicals is crucial to ensuring effluent quality. Therefore, it is necessary to further accelerate the dissolution rate of chemicals in water to achieve more precise water quality control.

[0004] Currently, most water treatment processes widely employ automated remote control, requiring continuous monitoring of water sample data to automatically adjust reagent dosages. However, since reagent dissolution and diffusion in water takes time, discrepancies can arise between instrument readings and overall water sample data, affecting reagent dosing effectiveness. Furthermore, traditional reagent mixing systems relying on large-scale aeration or mixing devices suffer from several problems. For instance, the power output of the mixer decreases with distance from the agitator or aeration pipe, or the aeration effect diminishes, leading to a sharp decrease in water flow velocity. This severely impacts reagent dissolution or significantly reduces dissolution efficiency, further increasing reagent usage and water treatment costs. Therefore, traditional reagent mixing systems have considerable room for optimization, making their modification and optimization crucial. Utility Model Content

[0005] The purpose of this invention is to provide a drug-assisted diffusion device that enables the drug to diffuse faster and more evenly during addition, allowing the drug to dissolve more quickly and completely. This makes the water sample data measured by the testing instrument closer to the actual overall condition of the water sample, improves the energy efficiency of the equipment, reduces the amount of drug used while improving the dissolution effect, and better improves water quality indicators.

[0006] To achieve the above objectives, this utility model provides a pharmaceutical-assisted diffusion device, installed in a reaction chamber, comprising:

[0007] The main frame includes a cylindrical body that extends through both ends. One end of the cylindrical body faces the bottom of the reaction chamber, and the other end faces away from the bottom of the reaction chamber. The cylindrical body has several holes on its wall.

[0008] A limiting unit is connected to the main frame. The limiting unit includes a first limiting component and a second limiting component. The first limiting component is used to limit the end of the cylinder away from the bottom of the reaction chamber from being lower than the liquid surface. The second limiting component is used to limit the cylinder below the drug inlet so that the drug added through the drug inlet falls into the cylinder.

[0009] An aeration assembly, which is connected to the main frame, is used to aerate the cylinder.

[0010] Optionally, the aeration assembly includes an aeration pipe connected to one end of the main frame facing the bottom of the reaction chamber, and the aeration pipe is provided with multiple aeration holes.

[0011] Optionally, the aeration assembly includes an air guide pipe, one end of which is connected to the aeration pipe, and the other end is used to introduce gas.

[0012] Optionally, the main frame includes a ventilation ring, which is connected to one end of the cylinder facing the bottom of the reaction chamber, and the air guide pipe is connected to the aeration pipe through the ventilation ring.

[0013] Optionally, the venting ring has at least two openings that communicate with the aeration pipeline, and the openings are evenly distributed on the venting ring.

[0014] Optionally, the main frame includes an annular frame and at least one support column. The annular frame is connected to one end of the cylinder away from the bottom of the reaction chamber, and the two ends of the support column are respectively connected to the annular frame and the venting ring.

[0015] Optionally, the annular frame is a hollow structure.

[0016] Optionally, the first limiting component includes at least one floating element, which is connected to one end of the main frame opposite to the bottom of the reaction chamber.

[0017] Optionally, the second limiting component includes a guide rail and a sliding bracket. The guide rail is fixedly connected to the side wall of the reaction chamber, and the main frame is connected to the sliding bracket. The sliding bracket can slide along the guide rail to change the height position of the main frame.

[0018] Optionally, the second limiting component includes a limiting member disposed at one end of the guide rail near the bottom of the reaction chamber to limit the lowest position of the main frame, thereby leaving a gap between the main frame and the bottom of the reaction chamber.

[0019] As configured above, this invention allows for precise aeration of the dosing area in the reaction chamber, resulting in faster and more uniform diffusion of the reagent during addition. This allows the water sample data measured by the testing instruments to more closely approximate the actual overall condition of the water sample, improving equipment energy efficiency. It enhances dissolution while reducing reagent usage and further improves water quality indicators. This invention can be used in combination with traditional aeration or stirring devices, allowing for pre-mixing of the reagent before it enters the existing reagent mixing system. This effectively improves the reagent's dissolution in the solvent, enabling faster and more complete dissolution and reducing the burden on the existing reagent mixing system. This invention boasts advantages such as strong practicality, compact structure, simple manufacturing, and low product cost. It can significantly reduce production costs and has great potential for widespread application, especially in water treatment processes, given the current emphasis on energy conservation, emission reduction, and cost reduction. Attached Figure Description

[0020] Those skilled in the art will understand that the accompanying drawings are provided to better understand the present invention and do not constitute any limitation on the scope of the present invention. Wherein:

[0021] Figure 1 This is a schematic diagram of a drug-assisted diffusion device according to an embodiment of the present invention;

[0022] Figure 2 This is a schematic diagram of the main frame and limiting unit of a drug-assisted diffusion device according to an embodiment of the present invention;

[0023] Figure 3 for Figure 2 Top view.

[0024] The accompanying figure is labeled as follows:

[0025] 1-Main frame; 11-Cylinder; 111-Hole; 12-Ventilation ring; 13-Annular frame; 14-Support column; 15-Rod; 2-Reaction chamber; 31-First limiting component; 32-Second limiting component; 321-Guide rail; 322-Sliding bracket; 3221-Sliding sleeve; 3222-Connecting rod; 3223-First reinforcing rod; 3224-Second reinforcing rod; 323-Limiting component; 4-Reagent dosing port; 51-Aeration pipeline; 511-Aeration hole; 52-Air guide pipeline. Detailed Implementation

[0026] In this document, unless otherwise stated, the terms “upper,” “lower,” “left,” “right,” “inner,” “outer,” “front,” “back,” “top,” “bottom,” etc., are used to indicate orientation or positional relationship based on the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, and are not intended to indicate or imply that the device or element referred to must have a characteristic orientation and operation, and therefore should not be construed as a limitation of the present invention.

[0027] The specific embodiments of this utility model will now be described in more detail with reference to the accompanying drawings. The advantages and features of this utility model will become clearer from the following description. It should be noted that the drawings are all in a very simplified form and use non-precise proportions, and are only used to facilitate and clarify the illustration of the embodiments of this utility model.

[0028] The preferred embodiments of this utility model are given below with reference to the accompanying drawings and described in detail.

[0029] Figure 1 This is a schematic diagram of a drug-assisted diffusion device according to an embodiment of the present invention. Figure 2 This is a schematic diagram of the main frame and limiting unit of a drug-assisted diffusion device according to an embodiment of the present invention. Figure 3 yes Figure 2 A top view. Please refer to... Figure 1 , Figure 2 and Figure 3 This utility model embodiment provides a drug-assisted diffusion device, which is installed in the reaction chamber 2. The auxiliary diffusion device includes a main frame 1, a limiting unit and an aeration component. The aeration component is connected to the main frame 1 and is used to aerate the main frame 1.

[0030] The main frame 1 includes a cylindrical body 11 extending through both ends, and an aeration assembly is used to aerate the cylindrical body 11. One end of the cylindrical body 11 faces the bottom of the reaction chamber 2, and the other end faces away from the bottom of the reaction chamber 2. The cylindrical body 11 has a plurality of holes 111 on its wall. The specific shape of the cylindrical body 11 is not limited; the cylindrical body 11 can be, for example, a cylinder, a square cylinder, or an irregularly shaped cylinder. In this embodiment, the cylindrical body 11 is a cylinder. For example, the cylindrical body 11 can have one end facing upward and the other end facing downward, and the cylindrical body 11 has a plurality of holes 111 evenly distributed on its wall.

[0031] The aeration assembly includes an aeration pipe 51, which is connected to one end of the main frame 1 facing the bottom of the reaction chamber 2. The aeration pipe 51 is provided with multiple aeration holes 511. The aeration assembly also includes an air guide pipe 52, one end of which is connected to the aeration pipe 51, and the other end is used to introduce gas, such as compressed air.

[0032] Preferably, the main frame 1 further includes a ventilation ring 12, which is connected to the end of the cylinder 11 facing the bottom of the reaction chamber 2. The air guide pipe 52 is connected to the aeration pipe 51 through the ventilation ring 12. The ventilation ring 12 has at least two openings that communicate with the aeration pipe 51, and the openings are evenly distributed on the ventilation ring 12. With this configuration, the gas in the air guide pipe 52 first enters the ventilation ring 12, and then enters the aeration pipe 51 from multiple points on the ventilation ring 12, making the aeration more uniform. The shape of the aeration pipe 51 is not limited. For example, the aeration pipe 51 can be a cross-shaped pipe. The aeration pipe 51 is located at the bottom of the cylinder 11, and multiple aeration holes 511 are evenly distributed on the side of the aeration pipe 51 facing the cylinder 11.

[0033] Preferably, the main frame 1 includes an annular frame 13 and at least one support column 14. The annular frame 13 is connected to the end of the cylinder 11 opposite to the bottom of the reaction chamber 2. The two ends of the support column 14 are connected to the annular frame 13 and the ventilation ring 12, respectively. The cylinder 11 encloses all the support columns 14 within the cylinder 11. The support columns 14 enhance the structural strength of the main frame 1. Furthermore, the annular frame 13 can be a hollow structure to increase buoyancy and make the entire main frame 1 float more easily. If the buoyancy is sufficient for floating, the annular frame 13 can be a solid structure. The support column 14 can be a solid plastic column.

[0034] The limiting unit is connected to the main frame 1. The limiting unit includes a first limiting component 31 and a second limiting component 32. The first limiting component 31 is used to prevent the end of the cylinder 11 away from the bottom of the reaction chamber 2 from falling below the liquid surface. The second limiting component 32 is used to restrict the cylinder 11 below the drug inlet 4, so that the drug added through the drug inlet 4 falls into the cylinder 11. Further, the first limiting component 31 includes at least one float. The float is connected to the end of the main frame 1 away from the bottom of the reaction chamber 2. In this embodiment, the float is connected to the annular frame 13 so that the main frame 1 floats on the liquid surface and the annular frame 13 does not fall below the liquid surface. The float can be, for example, a float ball, and the annular frame 13 is connected to four float balls.

[0035] The second limiting component 32 includes a guide rail 321 and a sliding bracket 322. The guide rail 321 is fixedly connected to the side wall of the reaction chamber 2. The main frame 1 is connected to the sliding bracket 322. The sliding bracket 322 is movably mounted on the guide rail 321. The sliding bracket 322 can slide along the guide rail 321 to change the height position of the main frame 1. It is understood that there should be a height difference between the two ends of the guide rail 321. One end of the guide rail 321 can be set close to the bottom of the reaction chamber 2, and the other end of the guide rail 321 can be set close to the top of the reaction chamber 2. The second limiting component 32 includes a limiting member 323, which is located at one end of the guide rail 321 near the bottom of the reaction chamber 2 to limit the lowest position of the main frame 1, so that there is a gap between the main frame 1 and the bottom of the reaction chamber 2, preventing the main frame 1 from touching the bottom when the liquid level in the reaction chamber 2 is too low. It is understood that if the main frame 1 touches the bottom, on the one hand, it will press on the air guide pipe 52, causing poor ventilation; on the other hand, the main frame 1 touching the bottom will affect the aeration effect, and the water flow will not be able to flow from the lower end of the main frame 1 into the main frame 1.

[0036] For example, the sliding bracket 322 includes a corresponding sliding sleeve 3221 and a connecting rod 3222. The sliding sleeve 3221 is loosely fitted onto the guide rail 321. The sliding sleeve 3221 can be an openable and closable annular structure to facilitate the installation or removal of the sliding sleeve 3221 from the guide rail 321. The sliding sleeve 3221 can be, for example, a snap-on plastic ring. One end of the connecting rod 3222 is connected to the sliding sleeve 3221, and the other end is connected to the main frame 1. Preferably, there are two guide rails 321, and each guide rail 321 is provided with at least one sliding sleeve 3221. Each sliding sleeve 3221 is connected to the main frame 1 through a connecting rod 3222. By setting two guide rails 321 in this way, the position of the main frame 1 is always restricted to directly below the drug inlet 4, ensuring that the drug falls into the main frame 1. The connecting rod 3222 can be connected to the main frame 1 via a rod 15 and a support column 14. The sliding support 322 may also include a first reinforcing rod 3223, which is simultaneously connected to the connecting rods 3222 on both guide rails 321 to improve the structural strength of the sliding support 322. When two or more sliding sleeves 3221 are provided on each guide rail 321, a second reinforcing rod 3224 can be connected between adjacent connecting rods 3222 on the same guide rail 321 to further improve the structural strength of the sliding support 322. When the liquid level in the reaction chamber changes, the main frame 1 can float up and down along the guide rails 321, maintaining its floating position on the liquid surface, thus enhancing the aeration effect and improving aeration efficiency.

[0037] Preferably, the diameter of the holes 111 is 4mm to 6mm, for example, 5mm, and the distance between adjacent holes 111 is 4mm to 6mm, for example, 5mm. This ensures the structural strength of the main frame 1 and allows the water flow driven by aeration to surge upwards along a predetermined path, rapidly increasing the dissolution rate of the chemicals. The size of the holes should not be too large, otherwise too much gas will overflow from the holes 111 into the cylinder 11, affecting the aeration effect, especially the aeration effect in the upper part of the cylinder 11.

[0038] When the agent-assisted diffusion device of this utility model is required to operate, the air guide pipe 52 inputs compressed air into the air ring 12, and the compressed air then enters the aeration pipe 51, and aerates through the aeration holes 511. The compressed air aeration drives the water flow to achieve rapid tumbling from bottom to top. At the same time, the agent is added and dripped from the agent addition port 4 above the main frame 1, and carried out by the rapidly tumbling water flow, quickly diffusing into the water body of the entire reaction chamber, achieving the first pre-dissolution. After the agent has undergone the first pre-dissolution, it will be dissolved and mixed again by the original agent mixing system (such as a stirrer, aeration system, etc.) after diffusing out of the main frame 1, thereby achieving a more complete and thorough dissolution of the agent.

[0039] The main frame 1 can be made of high-molecular organic materials, which have the advantages of being lightweight, corrosion-resistant, and easy to float.

[0040] With the above configuration, this invention can precisely aerate the dosing area of ​​reaction chamber 2, resulting in faster and more uniform diffusion of the reagent during dosing. This allows the water sample data measured by the testing instruments to more closely approximate the actual overall condition of the water sample, improving equipment energy efficiency. It enhances dissolution while reducing reagent usage and further improves water quality indicators. This invention can be used in combination with traditional aeration or stirring devices, allowing for pre-mixing of the reagent before it enters the existing reagent mixing system. This effectively improves the reagent's dissolution in the solvent, enabling faster and more complete dissolution and reducing the burden on the existing reagent mixing system. This invention boasts advantages such as strong practicality, compact structure, simple manufacturing, and low product cost. It can significantly reduce production costs and has great potential for widespread application, especially in water treatment processes, given the current emphasis on energy conservation, emission reduction, and cost reduction.

[0041] Compared to traditional large-scale aeration and mixing devices, this invention has the advantages of small size, simple structure, and low cost, and can be widely used in various water treatment systems. This invention provides precise aeration only in the chemical dosing area, reducing the cost of compressed air and other components by several times compared to traditional large-scale aeration devices. The aeration rate is a key factor affecting the effectiveness of aeration equipment. Because this invention is small and lightweight, the amount of compressed air used is easily controlled, allowing for better regulation of the aeration rate. Traditional aeration devices installed at the bottom of the tank require complete evacuation for maintenance, which not only consumes significant manpower and resources but also affects production. In contrast, this invention is small, mobile, and easy to disassemble; inspection and maintenance only require lifting it out of the liquid surface for easy removal.

[0042] It should be noted that references to "an embodiment," "an embodiment," "a specific embodiment," "some embodiments," etc., in the specification only indicate that the described embodiment may include a specific feature, structure, or characteristic. Furthermore, such phrases do not necessarily refer to the same embodiment. Additionally, when a specific feature, structure, or characteristic is described in conjunction with an embodiment, whether explicitly described or not, implementing such a feature, structure, or characteristic in conjunction with other embodiments is within the knowledge of those skilled in the art.

[0043] It should be noted that the various embodiments in this specification are described in a progressive manner, with each embodiment focusing on the differences from other embodiments. Similar or identical parts between embodiments can be referred to interchangeably. For the systems disclosed in the embodiments, since they correspond to the methods disclosed in the embodiments, the descriptions are relatively simple, and relevant parts can be referred to the method section.

[0044] It should also be noted that although the present invention has been disclosed above with reference to preferred embodiments, these embodiments are not intended to limit the present invention. For any person skilled in the art, many possible variations and modifications can be made to the present invention without departing from the scope of the present invention, or equivalent embodiments can be modified based on the disclosed technical content. Therefore, any simple modifications, equivalent changes, and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the present invention shall still fall within the protection scope of the present invention.

[0045] It should also be understood that, unless otherwise specified or indicated, the terms “first,” “second,” “third,” etc., in the specification are used only to distinguish the various components, elements, and steps in the specification, and not to indicate the logical or sequential relationships between the various components, elements, and steps.

[0046] Furthermore, it should be recognized that the terminology described herein is used only to describe particular embodiments and not to limit the scope of the invention. It must be noted that the singular forms “a” and “an” used herein and in the appended claims include plural bases unless the context clearly indicates otherwise. For example, a reference to “a step” or “an apparatus” means a reference to one or more steps or apparatuses, and may include secondary steps and secondary apparatuses. All conjunctions used should be understood in the broadest sense. Also, the word “or” should be understood to have the definition of logical “or” rather than logical “exclusive OR”, unless the context clearly indicates otherwise. Furthermore, implementation of the methods and / or devices in embodiments of the invention may include performing selected tasks manually, automatically, or in combination.

Claims

1. A medicament assisted diffusion device, said assisted diffusion device being installed in a reaction chamber, characterized in that, The auxiliary diffusion device comprises: a main frame comprising a cylinder through which two ends pass, one end of the cylinder is directed towards the bottom of the reaction cavity, the other end is away from the bottom of the reaction cavity, a plurality of holes are arranged on the cylinder wall of the cylinder; a limiting unit connected with the main frame, the limiting unit comprises a first limiting assembly and a second limiting assembly, the first limiting assembly is used to limit the end of the cylinder away from the bottom of the reaction cavity not to be lower than the liquid level, and the second limiting assembly is used to limit the cylinder below the medicament adding port, so that the medicament added by the medicament adding port falls into the cylinder; an aeration assembly connected with the main frame, the aeration assembly is used to aerate the cylinder.

2. The medicament-assisted diffusion device of claim 1, wherein, The aeration assembly comprises an aeration pipeline connected with one end of the main frame directed towards the bottom of the reaction cavity, and a plurality of aeration holes are arranged on the aeration pipeline.

3. The medicament-assisted diffusion device of claim 2, wherein, The aeration assembly comprises a gas guide pipeline, one end of the gas guide pipeline is communicated with the aeration pipeline, and the other end is used to introduce gas.

4. The medicament-assisted diffusion device of claim 3, wherein, The main frame comprises a ventilation ring connected with one end of the cylinder directed towards the bottom of the reaction cavity, and the gas guide pipeline is communicated with the aeration pipeline through the ventilation ring.

5. The medicament-assisted diffusion device of claim 4, wherein, The ventilation ring has at least two openings communicated with the aeration pipeline, and the openings are uniformly distributed on the ventilation ring.

6. The medicament-assisted diffusion device of claim 4, wherein, The main frame comprises an annular frame and at least one support, the annular frame is connected with one end of the cylinder away from the bottom of the reaction cavity, and the two ends of the support are respectively connected with the annular frame and the ventilation ring.

7. The medicament-assisted diffusion device of claim 6, wherein, The annular frame is an internal hollow structure.

8. The medicament-assisted diffusion device of claim 1, wherein, The first limiting assembly comprises at least one floating member connected with one end of the main frame away from the bottom of the reaction cavity.

9. The medicament-assisted diffusion device of claim 1, wherein, The second limiting assembly comprises a guide rail and a sliding support, the guide rail is fixedly connected with the side wall of the reaction cavity, the main frame is connected with the sliding support, and the sliding support can slide along the guide rail to change the height position of the main frame.

10. The medicament-assisted diffusion device of claim 9, wherein, The second limiting assembly comprises a limiting member arranged at one end of the guide rail close to the bottom of the reaction cavity to limit the lowest position of the main frame, so that a spacing is left between the main frame and the bottom of the reaction cavity.

Images